CASI Pharmaceuticals Current Assets

CASI Pharmaceuticals (CASIF) currently reports a current assets of $10M as of June 2026. That compares with $18M in the prior-year period — down 44.8% year over year. Use the charts on this page to explore CASI Pharmaceuticals's current assets history and peer comparisons.

CASI Pharmaceuticals's current assets decreased from $18M to $10M — a 44.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CASI Pharmaceuticals reported $10M in current assets as of June 2026. That compares with $18M in the prior-year period — down 44.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CASI Pharmaceuticals, and consider following CASIF for alerts when major investors trade the stock.

CASI Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $10M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CASIF with unrelated industries.